P35.4 Congenital Zika virus disease

Name of the Condition

• Congenital Zika virus disease
• ICD-10-CM Code: P35.4

Summary

This condition refers to Zika virus infection acquired by a fetus during pregnancy, resulting in congenital disease. The virus can affect multiple organ systems, with neurological manifestations being a primary concern. Clinical presentation varies, and some infants may be asymptomatic at birth but develop complications later.

Causes

Congenital Zika virus disease is caused by vertical transmission of the Zika virus from an infected mother to the fetus during pregnancy. The virus can cross the placenta and infect the developing fetus, leading to congenital abnormalities. Transmission occurs primarily through maternal infection, with the risk of severe outcomes highest when infection occurs in the first or second trimester.

Risk Factors

• Maternal Zika virus infection during pregnancy, particularly in the first or second trimester.
• Residence in or travel to areas with active Zika virus transmission.
• Lack of immunity to Zika virus (e.g., no prior infection or vaccination).
• Prolonged maternal viremia or high viral load.

Symptoms

Symptoms may include microcephaly, intracranial calcifications, ventriculomegaly, ocular abnormalities (e.g., chorioretinal atrophy), hearing loss, and joint contractures. Some infants may present with seizures, developmental delays, or failure to thrive. Not all infected infants show immediate symptoms.

Diagnosis

Diagnosis involves maternal history of Zika exposure or infection, fetal imaging (e.g., ultrasound or MRI) to assess structural abnormalities, and laboratory testing (e.g., PCR or serology) to confirm Zika virus infection. Postnatal testing of the infant may include PCR of blood or cerebrospinal fluid, and imaging to evaluate for brain or ocular abnormalities.

Treatment Options

There is no specific antiviral treatment for congenital Zika virus disease. Management focuses on supportive care, including monitoring for developmental delays, physical therapy, and interventions for specific complications (e.g., vision or hearing support). Multidisciplinary care involving neurologists, ophthalmologists, and developmental specialists is often required.

Prognosis and Follow-Up

Prognosis varies depending on the severity of neurological and systemic involvement. Infants with microcephaly or severe brain abnormalities may have long-term developmental challenges. Regular follow-up is essential to monitor growth, neurodevelopment, and organ function. Early intervention services can improve outcomes for affected children.

Complications

Complications may include severe microcephaly, intellectual disability, seizures, vision or hearing loss, and musculoskeletal abnormalities. Some infants may experience feeding difficulties or respiratory issues. Long-term complications can affect quality of life and require ongoing medical support.

Lifestyle & Prevention

Prevention focuses on reducing maternal Zika virus exposure, such as avoiding travel to endemic areas during pregnancy, using insect repellent, and practicing safe sex (e.g., condoms) to prevent sexual transmission. Pregnant individuals should consult healthcare providers for travel advisories and preventive measures.

When to Seek Professional Help

Seek medical attention if a pregnant individual experiences Zika virus symptoms (e.g., rash, fever, joint pain) or has been exposed to the virus. Newborns with suspected congenital Zika should be evaluated promptly for neurological or systemic abnormalities. Early referral to specialists is critical for managing complications.

Tips for Medical Coders

Code P35.4 is used for congenital Zika virus disease. Documentation should specify the timing of maternal infection (e.g., trimester) and any associated complications (e.g., microcephaly, ocular abnormalities) to support accurate coding. Ensure alignment with clinical findings and laboratory confirmation of Zika virus infection.